EAM-2201
EAM-2201 is a synthetic cannabinoid that has been identified in various herbal smoking blends. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body.
Chemical Structure and Properties[edit | edit source]
EAM-2201 belongs to the class of indole-based synthetic cannabinoids. Its chemical structure is similar to other synthetic cannabinoids such as JWH-018 and AM-2201. The molecular formula of EAM-2201 is C24H22N2O, and its IUPAC name is 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
Pharmacology[edit | edit source]
EAM-2201 acts as a full agonist at the CB1 receptor and CB2 receptor, which are the primary receptors in the endocannabinoid system. These receptors are involved in various physiological processes including pain sensation, mood, and memory. The binding affinity of EAM-2201 to these receptors is high, making it a potent synthetic cannabinoid.
Legal Status[edit | edit source]
The legal status of EAM-2201 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. For example, in the United States, EAM-2201 is listed as a Schedule I controlled substance under the Controlled Substances Act.
Health Effects and Risks[edit | edit source]
The use of EAM-2201 has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, and psychosis. Long-term use may lead to dependence and withdrawal symptoms. Due to its potency and the variability in the composition of herbal blends, the risk of overdose is significant.
Detection in Biological Samples[edit | edit source]
EAM-2201 can be detected in biological samples using various analytical techniques such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods are used in forensic and clinical toxicology to identify the presence of synthetic cannabinoids in urine, blood, and other tissues.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
